Literature DB >> 15870993

[Angiogenic factors in external auditory canal cholesteatoma-fibroblast cell culture].

R Naim1, H Sadick, C Bayerl, G Bran, K Hörmann.   

Abstract

BACKGROUND: The external auditory canal cholesteatoma (EACC) is characterized by hyperproliferation of the epithelial and subepithelial tissue. Compared to normal meatal skin, strong expression of FGF-2 and VEGF had previously been detected. Many authors reported that FGF-2 acts via VEGF and is induced by hypoxia. Hypoxia seems to be pivotal for establishing EACC. Therefore, human EACC fibroblasts were investigated by incubating with FGF-2 and determining VEGF. PATIENTS AND METHODS: We harvested fibroblasts from human EACC and normal meatal skin and incubated the fibroblast culture with 50 ng/ml FGF-2 and determined VEGF concentrations after 1-4 days.
RESULTS: Compared to untreated fibroblast cultures, there was a significant increase of VEGF concentration (p<0.05). However, there was no significant difference between the proliferation quantities.
CONCLUSION: VEGF and FGF-2 are possibly involved in a cascade of growth factor activities, which modulates their concentration in human-derived EACC fibroblast culture. Exogenous FGF-2 increased fibroblast expression for VEGF, which is a major autocrine mediator of FGF-2-induced angiogenesis and proliferation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15870993     DOI: 10.1007/s00106-005-1252-z

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  22 in total

1.  Keratinocytes promote proliferation and inhibit apoptosis of the underlying fibroblasts: an important role in the pathogenesis of keloid.

Authors:  Emi Funayama; Thinle Chodon; Akihiko Oyama; Tsuneki Sugihara
Journal:  J Invest Dermatol       Date:  2003-12       Impact factor: 8.551

2.  Requirement of Stat3 signaling for HGF/SF-Met mediated tumorigenesis.

Authors:  Yu-Wen Zhang; Ling-Mei Wang; Richard Jove; George F Vande Woude
Journal:  Oncogene       Date:  2002-01-10       Impact factor: 9.867

3.  Angiogenesis and angiogenic growth factors in middle ear cholesteatoma.

Authors:  H Sudhoff; S Dazert; A M Gonzales; G Borkowski; S Y Park; A Baird; H Hildmann; A F Ryan
Journal:  Am J Otol       Date:  2000-11

4.  Purification and characterization of a naturally occurring vascular endothelial growth factor.placenta growth factor heterodimer.

Authors:  J DiSalvo; M L Bayne; G Conn; P W Kwok; P G Trivedi; D D Soderman; T M Palisi; K A Sullivan; K A Thomas
Journal:  J Biol Chem       Date:  1995-03-31       Impact factor: 5.157

5.  Co-expression of different angiogenic factors in external auditory canal cholesteatoma.

Authors:  Ramin Naim; Frank Riedel; Karl Gotte; Gregor Bran; Haneen Sadick; Ulrich Gossler; Karl Hormann
Journal:  Acta Otolaryngol       Date:  2004-06       Impact factor: 1.494

6.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis.

Authors:  D Shweiki; A Itin; D Soffer; E Keshet
Journal:  Nature       Date:  1992-10-29       Impact factor: 49.962

7.  Keratosis obturans and external auditory canal cholesteatoma.

Authors:  M C Piepergerdes; B M Kramer; E E Behnke
Journal:  Laryngoscope       Date:  1980-03       Impact factor: 3.325

8.  [Basic fibroblast growth factor (b-FGF) in the perimatrix of cholesteatoma].

Authors:  C Milewski; A Fedorowski; A C Stan; G F Walter
Journal:  HNO       Date:  1998-09       Impact factor: 1.284

9.  Alteration in cholesteatoma fibroblasts: induction of neoplastic-like phenotype.

Authors:  S C Parisier; C J Agresti; G K Schwartz; J C Han; A P Albino
Journal:  Am J Otol       Date:  1993-03

10.  Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis.

Authors:  G Seghezzi; S Patel; C J Ren; A Gualandris; G Pintucci; E S Robbins; R L Shapiro; A C Galloway; D B Rifkin; P Mignatti
Journal:  J Cell Biol       Date:  1998-06-29       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.